Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
Nature reviews. Cancer2005Vol. 5(3), pp. 172–183
Citations Over TimeTop 1% of 2005 papers
Related Papers
- → Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia(2005)68 cited
- → Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia(2009)13 cited
- → Philadelphia-positive chronic myelogenous leukemia with breakpoint 5? of the breakpoint cluster region but within the bcr gene(1987)23 cited
- → Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib(2006)
- Expression of bcr/abl fusion gene in chronic myelogenous leukemia(2003)